by Usha Govindarajulu | Jun 23, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
June 22, 2022 In a recent article in News Medical Lifesciences, they have discussed a recent research paper published as an accepted manuscript in the Clinical Infectious Diseases journal in which the scientists analyzed the population immunity against pre-Omicron and...
by Usha Govindarajulu | Jun 9, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Usha Govindarajulu
June 9, 2022 In a recent article in the Boston Globe by Felicia Freyer, “‘Mild’ Omicron variant was highly lethal, the study finds that at least in Massachusetts, an Eastern state of the United States, that the Omicron variant of COVID-19 was not so mild. A...
by Usha Govindarajulu | Apr 13, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
Issues in COVID-19 research and statistical analyses (Part XVVVIII) April 13, 2022 In one of the latest Scientific American article, “What We Know about Omicron’s BA.2 Variant So Far”, the article summarizes some of the latest research about this new COVID-19 variant,...
by Usha Govindarajulu | Dec 22, 2021 | Biostatistics, Blog, COVID-19, Usha Govindarajulu
The new variant of COVID-19, Omicron, and boosters from vaccines has been receiving a lot of press. In an article published in BMJ on December 14, 2021, “Covid-19: Omicron and the need for boosters”, the authors take us through a detailed summary about how a booster...
